Avanos Medical (AVNS) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 130.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.21% |
| Dec 31, 2025 | 52.46% |
| Sep 30, 2025 | -28.61% |
| Jun 30, 2025 | -101.19% |
| Mar 31, 2025 | 6.92% |
| Dec 31, 2024 | -149.11% |
| Sep 30, 2024 | 29.41% |
| Jun 30, 2024 | -63.98% |
| Mar 31, 2024 | 27.23% |
| Dec 31, 2023 | 30.54% |
| Sep 30, 2023 | -34.92% |
| Jun 30, 2023 | -183.14% |
| Mar 31, 2023 | -28.77% |
| Dec 31, 2022 | -25.65% |
| Sep 30, 2022 | 43.52% |
| Jun 30, 2022 | 52.73% |
| Mar 31, 2022 | 31.35% |
| Dec 31, 2021 | -111.93% |
| Sep 30, 2021 | -118.31% |
| Jun 30, 2021 | 209.39% |
| Mar 31, 2021 | -34.18% |
| Dec 31, 2020 | -51.74% |
| Sep 30, 2020 | 5.15% |
| Jun 30, 2020 | 35.92% |
| Mar 31, 2020 | 31.00% |
| Dec 31, 2019 | 62.22% |
| Sep 30, 2019 | -48.33% |
| Jun 30, 2019 | -47.83% |
| Mar 31, 2019 | -50.80% |
| Dec 31, 2018 | -26.16% |
| Sep 30, 2018 | 26.18% |
| Jun 30, 2018 | -45.43% |
| Mar 31, 2018 | -2.36% |
| Dec 31, 2017 | 150.22% |
| Sep 30, 2017 | 61.89% |
| Jun 30, 2017 | -36.32% |
| Mar 31, 2017 | -33.14% |
| Dec 31, 2016 | -69.17% |
| Sep 30, 2016 | -42.51% |